These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3503823)

  • 1. Paucibacillary leprosy and W.H.O. regimen.
    Hazra S; Chaudhury S; Chaudhury SK; Das PK; Dey SK
    Indian J Dermatol; 1987 Oct; 32(4):99-101. PubMed ID: 3503823
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
    Koranne RV; Srivastava G
    Indian J Lepr; 1988 Jan; 60(1):90-2. PubMed ID: 3060548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 7. Borderline tuberculoid leprosy developing in a pure neuritic case.
    Porichha D; Mahapatra DC
    Indian J Lepr; 1991; 63(2):235-7. PubMed ID: 1783794
    [No Abstract]   [Full Text] [Related]  

  • 8. Histological changes in tuberculoid leprosy after fixed duration multidrug therapy for six months.
    Lavania RK; Girdhar A; Girdhar BK; Desikan KV
    Acta Leprol; 1990; 7(2):169-74. PubMed ID: 2220301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of paucibacillary leprosy by WHO regimen.
    Dey SK; Chanda M; Chowdhury A; Panja SK
    Indian J Dermatol; 1987 Jan; 32(1):11-3. PubMed ID: 3453349
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapse of paucibacillary leprosy after short course multidrug therapy.
    Pavithran K
    Indian J Lepr; 1988 Apr; 60(2):225-9. PubMed ID: 3192971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
    Katoch K; Ramu G; Ramanathan U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with two drug regimen in paucibacillary leprosy--preliminary report.
    Kaur S; Sharma VK; Kumar B; Kaur I
    Indian J Lepr; 1984; 56(1):48-9. PubMed ID: 6548244
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid therapy in recent "quiet nerve paralysis" in pure neuritic leprosy.
    Jaiswal AK; Shetty MK
    Indian J Lepr; 1991; 63(2):223-5. PubMed ID: 1783791
    [No Abstract]   [Full Text] [Related]  

  • 16. Short term WHO advised multiple drug treatment of paucibacillary patients.
    Naafs B; Lyons NF; Matemera BO; Ellis BP
    Indian J Lepr; 1986; 58(2):348-53. PubMed ID: 3805802
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 18. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of leprosy patients with single lesions to MDT.
    Katoch K; Natrajan M; Yadav VS; Bhatia AS
    Acta Leprol; 1995; 9(3):133-7. PubMed ID: 7631584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious side effects of rifampin on the course of WHO/MDT: a case report.
    Namisato M; Ogawa H
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):277-82. PubMed ID: 11221090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.